March 22, 2023
admin
Sudarshan Pharma Industries IPO Analysis at Chanakyanipothi.com,
the Oldest & the most Trusted Investment Blog in India. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.
Sudarshan Pharma Industries IPO
Sudarshan Pharma Industries IPO Grey Market updates
For latest updates, Click
Sudarshan Pharma IPO Subscription Status
On 14 March 2023 @ 5.00 pm (Closed)
QIB: 3259200 Shares, 1.01T
NII: 977760 Shares, 0.81T
RII: 2281440 Shares, 1.20T
Total: 6518400 Shares 1.06T
Sudarshan Pharma Industries: Company Details
Core business is manufacturing of Specialty Chemicals & Intermediates for Pharma, agro chemicals, Coating, paints, adhesive and various other industries. It is also into Active Pharmaceuticals Ingredients manufacturing. Some products it outsources and manufacturers at its toll manufacturing facility, it is also into specialty chemicals imports & exports as well as supply of same to the actual users. As per the clients need and requirements, it provides customize specialty chemicals to its clients in India and abroad regularly. Its Specialty chemicals & its Intermediates have wide application in sectors like pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries.
The company is also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
It carries about Ethical marketing of pharmaceutical formulation & products in the Domestic and International market through its own distribution network and Sales force under its own brands. Its Pharma & Specialty Chemical business operations are supported by various manufacturers having facilities which are approved by the FDA, WHO and other relevant authorities. It typically enters into contract manufacturing agreements for periods ranging from one to three years with the manufacturer of Pharma products.
For more information about the company, Click www.sudarshanpharma.com
| Sudarshan Pharma Industries IPO Details | |
| IPO opens on Tentative | 9 March 2023 |
| IPO closes on | 14 March 2023 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 6862400 Sh /Rs 50.10 Cr |
| * Fresh Issue | 6862400 Sh /Rs 50.10 Cr |
| * Offer for Sale | – Sh /Rs – Cr |
| Face Value per share: | Rs. 10 |
| Price Band | Rs.71-73 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 1600 Shares |
| Listing will at | BSE Sme |
| Shares offered to | ||
| Shares | Rs. (Cr) | |
| QIB (50 %) | 3259200 | 23.79 |
| NII (15 %) | 977760 | 7.14 |
| RII (35 %) | 2281440 | 16.65 |
| Total Shares | 6518400 | 47.58 |
| Retail portion will be oversubscribed by | 1426 | |
| Forms | ||
| How much Shares to Apply? | ||
| Min Retail Application | 1600 Sh | Rs. 116800 |
| Max Retail Application | 3200 Sh | Rs. 233600 |
Promoters of the IPO
MR. HEMAL VASANTRAI MEHTA & MR. SACHIN VASANTRAI MEHTA
Objects of the IPO:
The Company proposes to utilize the Net Proceeds from the Issue towards
Funding the working capital requirements
| IPO Tentative timetable | |
| IPO opens on | 9 March 2023 |
| IPO Closes on | 14 March 2023 |
| IPO Allotment on | 16 March 2023 |
| Unblocking of ASBA | 17 March 2023 |
| Credit of Shares | 20 March 2023 |
| Listing on | 21 March 2023 |
| Registered Office of the Company |
| 301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai City Maharashtra 400092 India. |
| IPO Lead Managers |
| GRETEX CORPORATE SERVICES LIMITED |
| Registrar to the IPO |
| KFIN TECHNOLOGIES PRIVATE LIMITED |
| IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs.in Cr | Rs.in Cr | Rs. | % | |
| 2019-20 | 148.00 | 1.28 | 1.34 | 6.43 |
| 2020-21 | 193.73 | 2.67 | 2.80 | 11.87 |
| 2021-22 | 357.56 | 5.30 | 5.52 | 17.81 |
| Book Value of the Share on | 31.03.2022 | Rs.19.23 | ||
| Book Value of the Share | after the IPO | Rs.40.65 | ||
| Offer Price | Rs. 73 | |||
| Ratio Analysis | |
| Upper Price/last EPS | 13.22 |
| Upper price/BV Ratio | 3.80 |
| Upper price/BV after IPO | 1.80 |
–
Sudarshan Pharma Industries IPO Peer Comparison:
| As on date of RHP | FV | Total | PE |
| Rs. | Income | Ratio of | |
| Rs. In Cr | |||
| The IPO Company | 10 | 355.47 | 13.22 |
| Eris Life Science | 10 | 282.14 | 89.11 |
| Sigachi Industries | 10 | 70.87 | 64.79 |
| Aarti Drugs | 10 | 551.20 | 63.68 |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
>>Go to Mainboard IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com
